Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Ena Wang"'
Autor:
David S. Stroncek, Paolo A. Ascierto, Michele Sommariva, Muna Al Hashmi, Francesco M. Marincola, Andrea Worschech, Sara Civini, Lotfi Chouchane, Jennifer Reinboth, Lorenzo Uccellini, Ben D. Ayotte, Qiuzhen Liu, Valeria De Giorgi, Sara Tomei, Davide Bedognetti, Giuseppe Palmieri, Maria Libera Ascierto, Ena Wang
Publikováno v:
Molecular oncology
(2014). doi:10.1016/j.molonc.2014.07.014
info:cnr-pdr/source/autori:Tomei S.; Bedognetti D.; De Giorgi V.; Sommariva M.; Civini S.; Reinboth J.; Al Hashmi M.; Ascierto M.L.; Liu Q.; Ayotte B.D.; Worschech A.; Uccellini L.; Ascierto P.A.; Stroncek D.; Palmieri G.; Chouchane L.; Wang E.; Marincola F.M./titolo:The immune-related role of BRAF in melanoma/doi:10.1016%2Fj.molonc.2014.07.014/rivista:Molecular oncology (Print)/anno:2014/pagina_da:/pagina_a:/intervallo_pagine:/volume
Journal of Translational Medicine
Molecular Oncology
Journal of translational medicine (Online) (2015): 1–2. doi:10.1186/1479-5876-13-S1-K19
info:cnr-pdr/source/autori:Tomei S.; Bedognetti D.; De Giorgi V.; Sommariva M.; Civini S.; Reinboth J.; Al Hashmi M.; Ascierto M.L.; Liu Q.; Ayotte B.D.; Worschech A.; Uccellini L.; Ascierto P.A.; Stroncek D.; Palmieri G.; Chouchane L.; Wang E.; Marincola F.M./titolo:The immune-related role of BRAF in melanoma/doi:10.1186%2F1479-5876-13-S1-K19/rivista:Journal of translational medicine (Online)/anno:2015/pagina_da:1/pagina_a:2/intervallo_pagine:1–2/volume
(2014). doi:10.1016/j.molonc.2014.07.014
info:cnr-pdr/source/autori:Tomei S.; Bedognetti D.; De Giorgi V.; Sommariva M.; Civini S.; Reinboth J.; Al Hashmi M.; Ascierto M.L.; Liu Q.; Ayotte B.D.; Worschech A.; Uccellini L.; Ascierto P.A.; Stroncek D.; Palmieri G.; Chouchane L.; Wang E.; Marincola F.M./titolo:The immune-related role of BRAF in melanoma/doi:10.1016%2Fj.molonc.2014.07.014/rivista:Molecular oncology (Print)/anno:2014/pagina_da:/pagina_a:/intervallo_pagine:/volume
Journal of Translational Medicine
Molecular Oncology
Journal of translational medicine (Online) (2015): 1–2. doi:10.1186/1479-5876-13-S1-K19
info:cnr-pdr/source/autori:Tomei S.; Bedognetti D.; De Giorgi V.; Sommariva M.; Civini S.; Reinboth J.; Al Hashmi M.; Ascierto M.L.; Liu Q.; Ayotte B.D.; Worschech A.; Uccellini L.; Ascierto P.A.; Stroncek D.; Palmieri G.; Chouchane L.; Wang E.; Marincola F.M./titolo:The immune-related role of BRAF in melanoma/doi:10.1186%2F1479-5876-13-S1-K19/rivista:Journal of translational medicine (Online)/anno:2015/pagina_da:1/pagina_a:2/intervallo_pagine:1–2/volume
Background The existence of a dichotomy between immunologically active and quiescent tumor phenotypes has been recently recognized in several types of cancer. The activation of a Th1 type of immune signature has been shown to confer better prognosis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::395923e4fb28c211808315282e37d85b
http://www.cnr.it/prodotto/i/289545
http://www.cnr.it/prodotto/i/289545
Autor:
Ena Wang
Publikováno v:
Journal of Translational Medicine
Journal of Translational Medicine, Vol 10, Iss Suppl 2, p A44 (2012)
Journal of Translational Medicine, Vol 10, Iss Suppl 2, p A44 (2012)
A cancer immune signature implicating good prognosis and responsiveness to immunotherapy was described that is observed also in other aspects of immune-mediated, tissue-specific destruction (TSD). Its determinism remains, however, elusive. On one sid
Autor:
Hui Liu, Jill Koshiol, Melissa Rotunno, Maria Teresa Landi, Ena Wang, Yingdong Zhao, Lisa M. McShane, Francesco M. Marincola
Publikováno v:
Journal of Translational Medicine, Vol 8, Iss 1, p 69 (2010)
Journal of Translational Medicine
Journal of Translational Medicine
Background MiR arrays distinguish themselves from gene expression arrays by their more limited number of probes, and the shorter and less flexible sequence in probe design. Robust data processing and analysis methods tailored to the unique characteri
Autor:
Ena Wang, Francesco M. Marincola
Publikováno v:
Journal of Translational Medicine
Journal of Translational Medicine, Vol 10, Iss Suppl 2, p A46 (2012)
Journal of Translational Medicine, Vol 10, Iss Suppl 2, p A46 (2012)
A cancer immune signature implicating good prognosis and responsiveness to immunotherapy was described that is observed also in other aspects of immune-mediated, tissue-specific destruction (TSD) [1,2]. Its determinism remains, however, elusive. On o
Autor:
James M Balwit, Davide Bedognetti, Bernard A. Fox, Lucia Gemma Delogu, Thomas F. Gajewski, Ena Wang, Mary L. Disis, Francesco M. Marincola, Sara Tomei, Lisa H. Butterfield, Cedrik M. Britten
Publikováno v:
Journal of Translational Medicine
Journal of Translational Medicine, Vol 9, Iss 1, p 155 (2011)
Journal of Translational Medicine, Vol 9, Iss 1, p 155 (2011)
Recent positive clinical results in cancer immunotherapy point to the potential of immune-based strategies to provide effective treatment of a variety of cancers. In some patients, the responses to cancer immunotherapy are durable, dramatically exten
Autor:
Roger S. Lo, Bastian Schilling, Francesco M. Marincola, David F. Stroncek, Silvia C. Formenti, Nicola Mozzillo, Rolf Kiessling, Pedro Romero, Sara Tomei, Alistair J. Cochran, Carlo Bifulco, Sandra Demaria, Igor Puzanov, Thomas F. Gajewski, Gennaro Ciliberto, Ena Wang, Grant Mc Arthur, Paul Lorigan, Giorgio Parmiani, Claus Garbe, Hassane M. Zarour, Alessandro Testori, Michael Davies, Gerardo Botti, Soldano Ferrone, Giuseppe Masucci, Janis M. Taube, Magdalena Thurin, Martin C. Mihm, Giuseppe Palmieri, Barbara Seliger, Samir N. Khleif, Paolo A. Ascierto, Reinhard Dummer, Michael B. Atkins, Ignacio Melero, Jérôme Galon
Publikováno v:
Journal of translational medicine, vol 13, iss 1
Journal of Translational Medicine, vol. 13, pp. 374
Journal of translational medicine (Online) (2015). doi:10.1186/s12967-015-0736-1
info:cnr-pdr/source/autori:Ascierto PA, Atkins M, Bifulco C, Botti G, Cochran A, Davies M,? Demaria S, Dummer R, Ferrone S, Formenti S, Gajewski TF, Garbe C, Khleif S, Kiessling R, Lo R, Lorigan P, Mc Arthur G, Masucci G, Melero I, Mihm M, Palmieri G, Parmiani G, Puzanov I, Romero P, Schilling B, Seliger B, Stroncek D, Taube J, Tomei S, Zarour HM, Testori A, Wang E, Galon J, Ciliberto G, Mozzillo N, Marincola F, Thurin M/titolo:Future perspectives in melanoma?research: meeting report from the "Melanoma Bridge": Napoli, December 3rd-6th 2014/doi:10.1186%2Fs12967-015-0736-1/rivista:Journal of translational medicine (Online)/anno:2015/pagina_da:/pagina_a:/intervallo_pagine:/volume
Journal of Translational Medicine
Journal of Translational Medicine, vol. 13, pp. 374
Journal of translational medicine (Online) (2015). doi:10.1186/s12967-015-0736-1
info:cnr-pdr/source/autori:Ascierto PA, Atkins M, Bifulco C, Botti G, Cochran A, Davies M,? Demaria S, Dummer R, Ferrone S, Formenti S, Gajewski TF, Garbe C, Khleif S, Kiessling R, Lo R, Lorigan P, Mc Arthur G, Masucci G, Melero I, Mihm M, Palmieri G, Parmiani G, Puzanov I, Romero P, Schilling B, Seliger B, Stroncek D, Taube J, Tomei S, Zarour HM, Testori A, Wang E, Galon J, Ciliberto G, Mozzillo N, Marincola F, Thurin M/titolo:Future perspectives in melanoma?research: meeting report from the "Melanoma Bridge": Napoli, December 3rd-6th 2014/doi:10.1186%2Fs12967-015-0736-1/rivista:Journal of translational medicine (Online)/anno:2015/pagina_da:/pagina_a:/intervallo_pagine:/volume
Journal of Translational Medicine
The fourth "Melanoma Bridge Meeting" took place in Naples, December 3-6th, 2014. The four topics discussed at this meeting were: Molecular and Immunological Advances, Combination Therapies, News in Immunotherapy, and Tumor Microenvironment and Biomar